Does COVID-19 Make a Better Case for Vaccines?

What Should Be Achieved in Phase 3 COVID-19 Vaccine Trials?

What to Make of the AstraZeneca COVID-19 Vaccine Trial Stalls

NIH: Expanding Trials for Convalescent Plasma

Average US COVID-19 Patient Age is Dropping

How Will COVID-19 Vaccines Be Distributed and Stored?

Innovative Device Looks to Filter Viruses

An Infectious Disease Expert Argues for ACA During COVID-19

Targeting Lung Blood Vessel Inflammation, Injury in COVID-19 Patients

Reaching a Majority in US COVID-19 Needs

COVID-19 Public Health Messaging Needs to Improve

Dialysis Data for SARS-CoV-2 Antibody Monitoring

Texas State Scientist on Rabies Eradication, Campus Reopening, and AMR

Safety Measures in Vaccine Related Clinic Visits During COVID-19

How COVID-19 Impacted Antibiotic Resistance | Dr. Debra Goff

Lessons Learned from One of the Earliest Cases of MIS-C

Addressing Hesitancy Before a COVID-19 Vaccine

Designing a Study to Investigate Gum Disease Associated Inflammation in SARS-CoV-2 Infection

Can Gum Disease Worsen COVID-19 Severity? Emerging Theories on Periodontal Connections

Avoiding Redundancy in Coronavirus Research

Do Pandemics Incentivize Cyclical Interest in Infectious Disease Funding, Research?

How COVID-19 Affects Sports Medicine

The Harms of Vaccine Hesitancy

Double Digit Decline in Infectious Disease Research During Coronavirus Pandemic

Where to Target Limited Coronavirus Testing Resources

Speed and Accuracy of COVID-19 Testing

Myocarditis Risk in COVID-Infected College Athletes

Testing Reagents for SARS CoV 2: Institutional Stockpiling and Supply Chain Issues

Professor of Medical Technology Provides COVID-19 Testing Breakdown

Targeting the Innate Immune System to Neutralize the Cytokine System in Severe COVID-19